Hospice Agencies Available for Sale Nationwide
A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.
A step-by-step hospice ownerâs guide to valuation multiples: how buyers think, what to prepare, how to avoid exit pitfalls, and protect your sale price.
Learn how hospice EBITDA multiples are set in todayâs marketâwhat drives the multiple, how compliance affects value, and how owners can prepare to maximize price.
Straight answers for hospice owners on multiples, valuation methods, compliance risk, buyer diligence, and what a professional hospice valuation typically costs.
Hospice M&A surged in late 2025, marking the strongest quarter since 2021. Learn what this means for hospice valuation, buyer demand, and selling strategy.
Getting a hospice valuation is more than a number â it shapes your exit timing, buyer confidence, and deal terms. Here are 10 questions every hospice owner should ask an advisor before starting the valuation process.
Closing is taking longer than ever for healthcare agency salesâoften 9â10+ monthsâbut that doesnât mean sellers are powerless. This guide explains why timelines have stretched, what really slows deals down, and how home health and home care owners can prepare in advance to protect valuation and stay in control of closing.
Closing is taking longer than ever for healthcare agency salesâoften 9â10+ monthsâbut that doesnât mean sellers are powerless. This guide explains why timelines have stretched, what really slows deals down, and how home health and home care owners can prepare in advance to protect valuation and stay in control of closing.
Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether youâre selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations â ensuring you achieve maximum value for your legacy.
The 2026 Final Rule and HOPE Tool are reshaping how hospice valuations are calculated. Learn how quality metrics, compliance, and data transparency affect your agencyâs value â and how Vallexa Advisors helps owners navigate the changing market.